Methamphetamine alters blood brain barrier protein expression in mice, facilitating central nervous system infection by neurotropic Cryptococcus neoformans

Journal of Infectious Diseases

Volumn 208, Issue 4, 2013, Pages 699-704

  Eugenin, Eliseo A ^a,b   Greco, Jade M ^c   Frases, Susana ^f   Nosanchuk, Joshua D ^d,e   Martinez, Luis R ^c,d,e  

^a PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c LONG ISLAND UNIVERSITY   (United States)

^d Department of Microbiology and Immunology ^*  (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^f FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Blood brain barrier; Cryptococcus neoformans; Methamphetamine

Indexed keywords

CELL ADHESION MOLECULE; METHAMPHETAMINE; TIGHT JUNCTION PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN INFECTION; CONTROLLED STUDY; CRYPTOCOCCOSIS; FUNGAL CELL; FUNGUS TRANSMISSION; INFECTION SENSITIVITY; MEMBRANE PERMEABILITY; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TIGHT JUNCTION;

BLOOD BRAIN BARRIER; CRYPTOCOCCUS NEOFORMANS; METHAMPHETAMINE;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; CELL ADHESION MOLECULES; CENTRAL NERVOUS SYSTEM STIMULANTS; CRYPTOCOCCUS NEOFORMANS; FEMALE; IMMUNOSUPPRESSIVE AGENTS; MENINGITIS, CRYPTOCOCCAL; METHAMPHETAMINE; MICE; MICE, INBRED C57BL; PROTEIN BIOSYNTHESIS; SURVIVAL ANALYSIS; TIGHT JUNCTION PROTEINS;

EID: 84880952947     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit117     Document Type: Article

References (26)

1. Martinez LR, Mihu MR, Gacser A, Santambrogio L, Nosanchuk JD. Methamphetamine enhances histoplasmosis by immunosuppression of the host. J Infect Dis 2009; 200:131-41.
2. Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 2009; 23:525-30.
3. Shi M, Li SS, Zheng C, et al. Real-time imaging of trapping and ureasedependent transmigration of Cryptococcus neoformans in mouse brain. J Clin Invest 2010; 120:1683-93.
4. Chang YC, Stins MF, McCaffery MJ, et al. Cryptococcal yeast cells invade the central nervous system via transcellular penetration of the blood-brain barrier. Infect Immun 2004; 72:4985-95.
5. Charlier C, Nielsen K, Daou S, Brigitte M, Chretien F, Dromer F. Evidence of a role for monocytes in dissemination and brain invasion by Cryptococcus neoformans. Infect Immun 2009; 77:120-7.
6. Carey CL, Woods SP, Rippeth JD, Gonzalez R, Heaton RK, Grant I. Additive deleterious effects of methamphetamine dependence and immunosuppression on neuropsychological functioning in HIV infection. AIDS Behav 2006; 10:185-90.
7. Simon SL, Richardson K, Dacey J, Glynn S, Domier CP, Rawson RA, Ling W. A comparison of patterns of methamphetamine and cocaine use. J Addict Dis 2002; 21:35-44.
8. Eugenin EA, Berman JW. Chemokine-dependent mechanisms of leukocyte trafficking across a model of the blood-brain barrier. Methods 2003; 29:351-61.
9. Sekine Y, Ouchi Y, Sugihara G, et al. Methamphetamine causes microglial activation in the brains of human abusers. J Neurosci 2008; 28:5756-61.
10. HIV & drugs. Meth use develops stronger link to HIV risk. AIDS Policy Law 2005; 20:5.
11. Ramirez SH, Potula R, Fan S, et al. Methamphetamine disrupts bloodbrain barrier function by induction of oxidative stress in brain endothelial cells. J Cereb Blood Flow Metab 2009; 29:1933-45.
12. Abdul Muneer PM, Alikunju S, Szlachetka AM, Murrin LC, Haorah J. Impairment of brain endothelial glucose transporter by methamphetamine causes blood-brain barrier dysfunction. Mol Neurodegener 2011; 6:23.
13. Avison MJ, Nath A, Greene-Avison R, Schmitt FA, Greenberg RN, Berger JR. Neuroimaging correlates of HIV-associated BBB compromise. J Neuroimmunol 2004; 157:140-6.
14. Quinton MS, Yamamoto BK. Causes and consequences of methamphetamine and MDMA toxicity. AAPS J 2006; 8:E337-47.
15. Bradbury MW. The blood-brain barrier. Exp Physiol 1993; 78:453-72.
16. Andras IE, Pu H, Tian J, Deli MA, Nath A, Hennig B, Toborek M. Signaling mechanisms of HIV-1 Tat-induced alterations of claudin-5 expression in brain endothelial cells. J Cereb Blood Flow Metab 2005; 25:1159-70.
17. Mahajan SD, Hu Z, Reynolds JL, Aalinkeel R, Schwartz SA, Nair MP. Methamphetamine modulates gene expression patterns in monocyte derived mature dendritic cells: implications for HIV-1 pathogenesis. Mol Diagn Ther 2006; 10:257-69.
18. Theodore S, Cass WA, Nath A, Maragos WF. Progress in understanding basal ganglia dysfunction as a common target for methamphetamine abuse and HIV-1 neurodegeneration. Curr HIV Res 2007; 5:301-13.
19. Volkow ND, Chang L, Wang GJ, et al. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry 2001; 158:377-82.
20. Aurrand-Lions M, Johnson-Leger C, Wong C, Du Pasquier L, Imhof BA. Heterogeneity of endothelial junctions is reflected by differential expression and specific subcellular localization of the three JAM family members. Blood 2001; 98:3699-707.
21. Bazzoni G, Martinez-Estrada OM, Orsenigo F, Cordenonsi M, Citi S, Dejana E. Interaction of junctional adhesion molecule with the tight junction components ZO-1, cingulin, and occludin. J Biol Chem 2000; 275:20520-6.
22. Martin-Padura I, Lostaglio S, Schneemann M, et al. Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration. J Cell Biol 1998; 142:117-27.
23. Hirase T, Staddon JM, Saitou M, et al. Occludin as a possible determinant of tight junction permeability in endothelial cells. J Cell Sci 1997; 110(Pt 14):1603-13.
24. Collins NT, Cummins PM, Colgan OC, et al. Cyclic strain-mediated regulation of vascular endothelial occludin and ZO-1: influence on intercellular tight junction assembly and function. Arterioscler Thromb Vasc Biol 2006; 26:62-8.
25. Ellis RJ, Childers ME, Cherner M, Lazzaretto D, Letendre S, Grant I. Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy. J Infect Dis 2003; 188:1820-6.
26. Nimrichter L, Frases S, Cinelli LP, et al. Self-aggregation of Cryptococcus neoformans capsular glucuronoxylomannan is dependent on divalent cations. Eukaryot Cell 2007; 6:1400-10.